Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of method of synthesizing trametinib

A synthesis method and technology of iodophenylamino group, applied in the field of pharmaceutical synthesis, can solve the problems of difficult control of intermediates, cumbersome routes, cumbersome operations and the like, and achieve the effects of low cost, easy operation and shortened process flow

Active Publication Date: 2021-03-16
安庆奇创药业有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many steps in this method, and the one-step yield of compound 5 obtained by condensation is relatively low.
[0005] Even if the advantages and disadvantages of the two methods are complemented, only the raw materials of the condensation step and the replacement step with lower yields can be changed, which may have a certain effect on improving the overall yield, but the idea of ​​​​reaction route design has not been changed, and the operation remains the same. More cumbersome and difficult to solve problems with many steps
[0006] Of course, Med Chem Lett, 2011, 2(6), 320-324 reported a sequence of introducing substituted anilines that is different from the above two methods, that is, the 3-acetamidoaniline structure is firstly constructed into a ring, and finally 2 -Fluoro-4-iodoaniline, the advantage of this method is that it avoids the amide exchange process under alkaline conditions in the first two methods, but the whole route is relatively cumbersome, the control of intermediates is difficult, and the process stability will face greater difficulties

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of method of synthesizing trametinib
  • A kind of method of synthesizing trametinib
  • A kind of method of synthesizing trametinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] according to image 3 The shown route diagram prepares synthetic trametinib:

[0035] S1: In N-(2-fluoro-4-iodophenyl)-N'-methylurea (15g, 51.0mmol) and triethylamine (28.3mL, 204mmol) in dichloromethane (250mL), add CBr 4 (33.8g, 102mmol) and triphenylphosphine (26.8g, 102mmol), react at room temperature for 6h, and concentrate to obtain crude N-(2-fluoro-4-iodophenyl)-N'-methylcarbodiimide; To a solution of diethyl 2-methyl-3-oxo-glutaric acid (9.56g, 44.2mmol) in dry THF (100mL), add sodium ethoxide (50mmol) at 0°C, and slowly add the crude product in THF dropwise (150mL) solution, react at room temperature for 2h, and react at 50°C for 12h, add dilute hydrochloric acid (1mol / L, 80ml), ethyl acetate (50mL once, three times in total) to extract the aqueous phase, combine the organic layers, wash with water, and dry , filtered, concentrated, and separated on a silica gel column (200 mesh, mobile phase cyclohexane / ethyl acetate), to obtain oil 2-(2-fluoro-4-iodophenylam...

Embodiment 2

[0039] S1: In N-(2-fluoro-4-iodophenyl)-N'-methylurea (15g, 51.0mmol) and triethylamine (28.3mL, 204mmol) in dichloromethane (250mL), add CBr 4 (33.8g, 102mmol) and triphenylphosphine (26.8g, 102mmol), react at room temperature for 6h, and concentrate to obtain crude N-(2-fluoro-4-iodophenyl)-N'-methylcarbodiimide; To a solution of diethyl 2-methyl-3-oxo-glutaric acid (9.36g, 43.4mmol) in dry THF (100mL), add sodium ethoxide (45.9mmol) at 0°C, and slowly add the crude product THF (150mL) solution, reacted at room temperature for 2h, and reacted at 40°C for 14h, added dilute hydrochloric acid (1mol / L, 80ml), ethyl acetate (50mL once, three times in total) to extract the aqueous phase, combined the organic layers, washed with water, Dry, filter, concentrate, and separate on a silica gel column (200 mesh, mobile phase cyclohexane / ethyl acetate) to obtain the oil 2-(2-fluoro-4-iodophenylamino)-4-hydroxyl-1,5- Dimethyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid ethyl ester (8.2g)...

Embodiment 3

[0043] S1: In N-(2-fluoro-4-iodophenyl)-N'-methylurea (15g, 51.0mmol) and triethylamine (28.3mL, 204mmol) in dichloromethane (250mL), add CBr 4 (33.8g, 102mmol) and triphenylphosphine (26.8g, 102mmol), react at room temperature for 6h, and concentrate to obtain crude N-(2-fluoro-4-iodophenyl)-N'-methylcarbodiimide; To a solution of diethyl 2-methyl-3-oxo-glutarate (11.03g, 51mmol) in dry THF (100mL), add sodium ethoxide (56.1mmol) at 0°C, and slowly add the crude product in THF dropwise (150mL) solution, react at room temperature for 2h, and react at 60°C for 10h, add dilute hydrochloric acid (1mol / L, 80ml), ethyl acetate (50mL once, three times in total) to extract the aqueous phase, combine the organic layers, wash with water, and dry , filtered, concentrated, and separated on a silica gel column (200 mesh, mobile phase cyclohexane / ethyl acetate), to obtain oil 2-(2-fluoro-4-iodophenylamino)-4-hydroxyl-1,5-di Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid ethyl ester (8...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing trametinib. The method comprises the steps of dehydrating N-(2-fluoro-4-iodophenyl)-N'-methylurea to form carbodiimide, then enabling the product to be subjected to a cyclization reaction with 2-methyl-3-oxo-diethyl glutarate to obtain 2-(2-fluoro-4-iodophenylamino)-4-hydroxyl-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-nonanoic acid-ethyl ester; after that, carrying out cyclization on the obtained product with N-(3-nitrophenyl)-N'-cyclopropyl urea to obtain 3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-methyl-1-(3-nitrophenyl)pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione; finally, reducing a nitro group first, then performing acetylation to obtain the trametinib. The invention provides a new synthesis route of the trametinib by means of retrosynthetic analysis, and can greatly shorten the technological process; furthermore, expensive reagents are not used in a preparation process; the method has the advantages of being simple and convenient to operate and lower in cost; a reference is provided for the preparation of the trametinib.

Description

technical field [0001] The invention relates to the field of drug synthesis, in particular to a synthesis method of trametinib. Background technique [0002] The Chinese chemical name of Trametinib: N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetra Hydrogen-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide, developed by GlaxoSmithKline , Trametinib approved by the U.S. FDA on May 29, 2013, was launched in the U.S. under the trade name Mekinist. For the treatment of unresectable or metastatic melanoma with BRAF (murine sarcoma virulence oncogenic homologue B1 gene) V600E or V600K mutation. [0003] ACS Medicinal Chemistry Letters, 2011,2(4),320-324 reported its synthetic method, as figure 1 Shown: Urea 1 was prepared by using 2-fluoro-4-iodophenylisocyanate and cyclopropylamine, and then cyclized with malonic acid to obtain pyrimidinetrione compound 2, pyrimidinetrione compound 2 and POCl 3 Selective chlorination to obtain chlorina...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04
CPCC07D471/04
Inventor 吴学平海威时珠勇
Owner 安庆奇创药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products